News
89Bio Launches into Liver and Metabolic Disorders with $ www.finanzen.ch › News & Analysen › News
www.finanzen.ch
Rohan Palekar joins as CEO. About NASH NASH is the most advanced stage of nonalcoholic fatty liver disease (NAFLD). It is a complex ...
89bio Reports Fourth Quarter and Full Year Financial
www.globenewswire.com
- BIO Phase 1b/2a NASH study on track for topline data in 2H Initiation of Phase 2 SHTG study planned in 1H SAN FRANCISCO, March 18,...
89bio to Present at the SVB Leerink 9th Annual AP Newsapnews.com › ...
apnews.com
... and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that Rohan Palekar, ...
sorted by relevance / date